Skandinaviska Enskilda Banken (SEB)
TBIO

Skandinaviska Enskilda Banken (SEB)’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,400
Closed -$81K – 1227
2020
Q4 		$81K Hold
4,400
– – ﹤0.01% 1059
2020
Q3 		$60K Sell
4,400
-12,400
-74% -$191K ﹤0.01% 961
2020
Q2 		$301K Buy
+16,800
New +$253K ﹤0.01% 872

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s TBIO Position: Q1 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2021, closing a stake of 4,400 shares — an estimated $81K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in TBIO in Q2 2020 and held it in 3 quarters. The position peaked at $301K in Q2 2020. 146 funds tracked by Wall St. Rank hold TBIO as of Q1 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 4,400 Translate Bio, Inc. Common Stock shares in Q1 2021, an estimated $81K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Translate Bio, Inc. Common Stock position peaked at $301K in Q2 2020.
  • 146 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2021, filed 14 May 2021.